CGCarlyle Group Inc.

Nasdaq carlyle.com


$ 40.97 $ -3.83 (-8.55 %)    

Wednesday, 01-May-2024 15:59:55 EDT
QQQ $ 424.96 $ -0.28 (-0.07 %)
DIA $ 378.81 $ 0.76 (0.2 %)
SPY $ 500.35 $ -1.63 (-0.32 %)
TLT $ 88.50 $ 0.65 (0.74 %)
GLD $ 211.79 $ -0.67 (-0.32 %)
$ 40.97
$ 40.66
$ 0.00 x 0
$ 0.00 x 0
$ 40.50 - $ 42.77
$ 24.14 - $ 48.52
6,031,370
na
14.92B
$ 1.49
nm
TBD
na
na ($ 0.03)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 02-22-2024 12-31-2023 10-K
2 11-07-2023 09-30-2023 10-Q
3 08-02-2023 06-30-2023 10-Q
4 05-04-2023 03-31-2023 10-Q
5 02-09-2023 12-31-2022 10-K
6 11-08-2022 09-30-2022 10-Q
7 07-28-2022 06-30-2022 10-Q
8 04-28-2022 03-31-2022 10-Q
9 02-10-2022 12-31-2021 10-K
10 10-28-2021 09-30-2021 10-Q
11 07-29-2021 06-30-2021 10-Q
12 04-29-2021 03-31-2021 10-Q
13 02-11-2021 12-31-2020 10-K
14 10-29-2020 09-30-2020 10-Q
15 07-31-2020 06-30-2020 10-Q
16 04-30-2020 03-31-2020 10-Q
17 02-12-2020 12-31-2019 10-K
18 10-31-2019 09-30-2019 10-Q
19 07-31-2019 06-30-2019 10-Q
20 05-01-2019 03-31-2019 10-Q
21 02-13-2019 12-31-2018 10-K
22 10-31-2018 09-30-2018 10-Q
23 08-01-2018 06-30-2018 10-Q
24 05-01-2018 03-31-2018 10-Q
25 02-15-2018 12-31-2017 10-K
26 10-31-2017 09-30-2017 10-Q
27 08-02-2017 06-30-2017 10-Q
28 05-03-2017 03-31-2017 10-Q
29 02-16-2017 12-31-2016 10-K
30 11-03-2016 09-30-2016 10-Q
31 08-03-2016 06-30-2016 10-Q
32 05-04-2016 03-31-2016 10-Q
33 02-24-2016 12-31-2015 10-K
34 11-05-2015 09-30-2015 10-Q
35 08-05-2015 06-30-2015 10-Q
36 05-07-2015 03-31-2015 10-Q
37 02-26-2015 12-31-2014 10-K
38 11-06-2014 09-30-2014 10-Q
39 08-07-2014 06-30-2014 10-Q
40 05-08-2014 03-31-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 oppenheimer-maintains-outperform-on-carlyle-group-lowers-price-target-to-68

Oppenheimer analyst Chris Kotowski maintains Carlyle Group (NASDAQ:CG) with a Outperform and lowers the price target from $7...

 carlyle-group-q1-2024-adj-eps-101-beats-094-estimate

Carlyle Group (NASDAQ:CG) reported quarterly earnings of $1.01 per share which beat the analyst consensus estimate of $0.94 by ...

 carlyle-group-q1-sales-1023b-beat-993283m-estimate

Carlyle Group (NASDAQ:CG) reported quarterly sales of $1.023 billion which beat the analyst consensus estimate of $993.283 mill...

 ig-metall-says-we-take-a-critical-view-towards-possible-ipo-via-spin-off-first-round-of-talks-with-small-group-of-participants-planned-for-start-of-may-carlyle-is-in-process-of-due-diligence-for-a-majority-stake-in-tkms

- Reuters

 german-ig-metall-union-says-held-first-talks-last-week-with-carlyle-on-possible-investment-in-thyssenkrupp-marine-systems-there-can-only-be-a-sale-to-private-equity-investors-if-state-accepts-its-responsibility-and-steps-in-to-secure-naval-shipbuilding-agreed-with-carlyle-to-conclude-a-best-and-fair-owner-agreement-as-quickly-as-possible

- Reuters

 carlyle-group-said-to-review-options-for-tamko-including-sale

- Bloomberg

 carlyle-founders-ordered-to-face-lawsuit-on-344m-payout---bloomberg-law

https://news.bloomberglaw.com/securities-law/carlyle-founders-ordered-to-face-lawsuit-on-344-million-payout Case targets tax bu...

 ubs-maintains-neutral-on-carlyle-group-raises-price-target-to-50

UBS analyst Brent Dilts maintains Carlyle Group (NASDAQ:CG) with a Neutral and raises the price target from $46 to $50.

 barclays-maintains-overweight-on-carlyle-group-raises-price-target-to-56

Barclays analyst Benjamin Budish maintains Carlyle Group (NASDAQ:CG) with a Overweight and raises the price target from $55 ...

 carlyle-group-mulls-10b-sale-of-standardaero-sources-say

- Reuters

 tian-tu-plunges-into-the-red-on-sagging-hong-kong-stock-market

Key Takeaways: Tian Tu Capital posted an 873 million yuan net loss last year, reversing a 559 million yuan profit in 2022 T...

Core News & Articles

Collaboration combines Teva's expertise in respiratory technology development and Launch Therapeutics' innovative late-...

 carlyle-names-lindsay-lobue-as-coo-effective-july-1-2024---filing

Chris Finn, Carlyle’s current Chief Operating Officer, will stay in his role through June 30, 2024, and will become a Senior Ad...

 carlyle-and-bmo-team-up-unveil-private-equity-strategy-for-canada

Carlyle Group and BMO Global partner to launch private equity strategy for Canada, offering global access to accredited investo...

 carlyle-inks-pact-with-bmo-global-asset-management-to-launch-private-equity-strategy-for-canada

BMO Global Asset Management (BMO GAM) today announced its third collaboration to broaden access to private markets for Canadian...

Core News & Articles

Thyssenkrupp reviews possible partial sale of Marine Systems to Carlyle. Both companies agreed to enter into an in-depth examin...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION